Vaccine development against Neisseria meningitidis

Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based onNeisseria lactamicaouter membrane vesicles

(2011) Michelle Finney et al.   Human vaccines & immunotherapeutics

Meningococcal B vaccine development and evaluation of efficacy

(2010) Loek van Alphen et al.   Human vaccines & immunotherapeutics

Evaluation of a Whole-Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B Neisseria meningitidis Vaccines Made from Lipid A Acylation Mutants

(2009) M. B. Stoddard et al.   Clinical and Vaccine Immunology

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

(2009) R. Borrow et al.   Clinical and Vaccine Immunology

Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles

(2009) A. R. Gorringe et al.   Clinical and Vaccine Immunology

Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response

(2009) V. Weynants et al.   INFECTION AND IMMUNITY

Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen ofNeisseria meningitidis

(2009) Francesca Cantini et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Vaccinology in the genome era

(2009) C. Daniela Rinaudo et al.   JOURNAL OF CLINICAL INVESTIGATION

Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales

(2009) J. Lucidarme et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Vaccines Containing de- N -Acetyl Sialic Acid Elicit Antibodies Protective against Neisseria meningitidis Groups B and C

(2009) Gregory R. Moe et al.   JOURNAL OF IMMUNOLOGY

Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis

(2009) Ellen Murphy et al.   JOURNAL OF INFECTIOUS DISEASES

The modular architecture of meningococcal factor H-binding protein

(2009) P. T. Beernink et al.   MICROBIOLOGY-SGM

Variation of the factor H-binding protein of Neisseria meningitidis

(2009) C. Brehony et al.   MICROBIOLOGY-SGM

Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates

(2009) Muriel C. Schneider et al.   NATURE

Secreted proteins of Neisseria meningitidis protect mice against infection

(2009) Yanwen Li et al.   VACCINE

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

(2009) Stefania Bambini et al.   VACCINE

Meningococcal protein antigens and vaccines

(2009) Ian M. Feavers et al.   VACCINE

Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide

(2009) Lisa K. McNeil et al.   VACCINE

Distribution of transferrin binding protein B gene (tbpB) variants among Neisseria species

(2008) Odile B Harrison et al.   BMC MICROBIOLOGY

Meningococcal Outer Membrane Protein NhhA Is Essential for Colonization and Disease by Preventing Phagocytosis and Complement Attack

(2008) H. Sjolinder et al.   INFECTION AND IMMUNITY

Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants

(2008) Matthew D. Snape et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086

(2008) Alessandro Mascioni et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES

Amino acid 310 determines the donor substrate specificity of serogroup W-135 and Y capsule polymerases ofNeisseria meningitidis

(2008) Heike Claus et al.   MOLECULAR MICROBIOLOGY

Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis

(2008) C. O. Buckee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis

(2008) C. Schoen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous inNeisseria meningitidis with vaccine potential

(2008) Chi-An Hsu et al.   PROTEOMICS

Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA

(2008) Annalisa Ciabattini et al.   VACCINE

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

(2008) Caroline L. Trotter et al.   VACCINE

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years

(2008) Lars Østergaard et al.   VACCINE

Characterization of ST-4821 complex, a unique Neisseria meningitidis clone

(2007) Junping Peng et al.   GENOMICS